COMMUNIQUÉS West-GlobeNewswire

HealthLynked Corp. Announces Partnership to Offer Discount Medical Supplies to its Members and Healthcare Providers

13/09/2018 - 11:00

NAPLES, Fla., Sept. 13, 2018 (GLOBE NEWSWIRE) -- HealthLynked Corp. (OTCQB: HLYK) today announced its partnership with MedOfficeDirect, LLC, an online retailer of discount medical supplies. MedOfficeDirect sells [...]

Solon Eiendom ASA – Primary insider notification

13/09/2018 - 08:30

(Oslo, Norway, September 12, 2018) Solon Eiendom ASA Board Member Tore Aksel Voldberg has today through his wholly owned company Skøien AS bought 10.000 shares in Solon Eiendom ASA at a price of NOK 29,0632. Following [...]

Shire plc : Rule 2.9 Announcement

13/09/2018 - 08:00

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 13 September 2018 [...]

ERYTECH to Attend Upcoming Investor Conferences

13/09/2018 - 07:30

LYON, France, Sept. 13, 2018 (GLOBE NEWSWIRE) -- ERYTECH Pharma (Euronext Paris: ERYP - Nasdaq: ERYP), a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating drug substances inside [...]

ERYTECH participera à plusieurs conférences d'investisseurs

13/09/2018 - 07:30

LYON, France, 13 sept. 2018 (GLOBE NEWSWIRE) -- ERYTECH Pharma (Euronext : ERYP – Nasdaq : ERYP), société biopharmaceutique de stade clinique qui développe des thérapies innovantes en encapsulant des médicaments dans [...]

ESPERITE N.V. (ESP) WITH CRYOSAVE READY TO STORE MORE THAN A MILLION SAMPLES IN ITS NEW DESIGNED CRYOSTORAGE FACILITY IN GENEVA.

13/09/2018 - 07:18

CryoSave has fully equipped this new safe and secure sample storage BioBank in its state-of-the-art central laboratory in Geneva, Switzerland especially designed for optimal cryopreservation of all biological samples [...]

Novartis real-world evidence confirms efficacy and safety benefits of Cosentyx® in daily life for psoriasis patients

13/09/2018 - 07:16

Real-world evidence confirms Cosentyx ® efficacy and safety consistent with previously reported clinical studies [1]-[4] Novartis presents a large program of real-world evidence at the 27 th European Academy of [...]

Abeona Therapeutics annonce l'autorisation de commencer l'étude clinique de phase 1/2 sur la thérapie génique pour les patients atteints de MPS IIIB en Espagne

13/09/2018 - 05:51

Un essai clinique pour ABO-101 (AAV-NAGLU) marque le 2e programme MPS III en Europe La société prévoit de créer des sites cliniques supplémentaires dans certains pays européens, dont la France, l'Allemagne et le Royaume [...]

Galapagos raises $300 million gross proceeds in a U.S. public offering

13/09/2018 - 03:16

Mechelen, Belgium, 13 September 2018, 03.00 CET, regulated information - Galapagos NV (Euronext & NASDAQ: GLPG) announced today the pricing of its U.S. public offering totaling $ 300 million gross proceeds of 2,575, [...]

Xenon Pharmaceuticals Announces Pricing of $63.0 Million Public Offering of Common Shares

13/09/2018 - 02:15

BURNABY, British Columbia, Sept. 12, 2018 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a clinical stage, neurology-focused biopharmaceutical company, today announced the pricing of its underwritten [...]

XBiotech annonce l’arrivée d’un éminent cardiologue de renommée mondiale, le Dr. Peter Libby qui rejoint son Comité scientifique consultatif

13/09/2018 - 02:10

AUSTIN, Texas, 13 sept. 2018 (GLOBE NEWSWIRE) -- XBiotech Inc. (NASDAQ : XBIT) a le plaisir d’annoncer la nomination au sein de son Comité scientifique consultatif de Peter Libby, MD. Le Dr. Libby travaillera avec [...]

Resverlogix Announces Voting Results from the 2018 Annual and Special Meeting of Shareholders

13/09/2018 - 00:30

CALGARY, Alberta, Sept. 12, 2018 (GLOBE NEWSWIRE) -- Resverlogix Corp. (“Resverlogix”, or the "Corporation") (TSX:RVX) today held its Annual and Special Meeting of Shareholders (the “Meeting”) in Calgary, Alberta. A [...]

Zenith Announces Voting Results from the 2018 Annual Meeting of Shareholders

13/09/2018 - 00:00

Archive of the Executive Presentation to be Posted to the Zenith Website CALGARY, Alberta, Sept. 12, 2018 (GLOBE NEWSWIRE) -- Zenith Capital Corp. ("Zenith" or the "Company") announces that, at its annual meeting of [...]

Novartis announces NEJM publication of landmark PARADIGMS study demonstrating significant benefit of Gilenya® in children and adolescents with MS

12/09/2018 - 23:01

Treatment with Gilenya (fingolimod) substantially reduced the debilitating impact of MS, with significant decreases in key measures of disease activity vs. interferon beta-1a MS severely affects the everyday lives of [...]

Galapagos announces launch of proposed public offering

12/09/2018 - 22:54

Mechelen, Belgium, 12 September 2018, 22.45 CET, regulated information - Galapagos NV (Euronext & NASDAQ: GLPG) announced today that it intends to offer and sell, subject to market and other conditions, $300 million [...]

Foamix Announces Proposed Follow-on Offering of Ordinary Shares

12/09/2018 - 22:31

REHOVOT, Israel, and BRIDGEWATER, N.J., Sept. 12, 2018 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (“Foamix”) (Nasdaq: FOMX), a clinical-stage specialty pharmaceutical company focused on developing and [...]

Clearside Biomedical Appoints Viral Kansara as Vice President, Discovery

12/09/2018 - 22:30

ALPHARETTA, Ga., Sept. 12, 2018 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company dedicated to developing treatments that restore and preserve vision for people with serious eye [...]

Adamas Announces New Employment Inducement Grant

12/09/2018 - 22:30

EMERYVILLE, Calif., Sept. 12, 2018 (GLOBE NEWSWIRE) -- Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS) today announced that the compensation committee of the company’s board of directors granted six new employees the option [...]

Verrica Announces Successful Phase 2 Innovate Trial and Complete Enrollment of Phase 3 Trials of VP-102 in Molluscum Contagiosum Ahead of Schedule

12/09/2018 - 22:05

Innovate trial results reaffirm Phase 3 protocol design No serious adverse events (SAEs) reported during the Innovate trial Phase 3 pivotal trials for molluscum contagiosum fully enrolled and topline results now [...]